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Late incidence of chronic venous insufficiency
after deep vein harvest
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Frank R. Arko III, MD,a R. James Valentine, MD,a and G. Patrick Clagett, MD,a Dallas, Tex
Background:The deep veins (DV) of the thigh have proven to be versatile autogenous conduits for arterial reconstruction.
Harvesting DV poses a theoretical risk of compromising venous outflow of the limb, which could predispose to chronic
venous morbidity. The purpose of this study was to define the late incidence of chronic venous insufficiency (CVI) and to
characterize the long-term alterations in venous physiology after DV harvest.
Methods: Since 1991, 269 patients have undergone arterial reconstructions using DV at our facility. Patients with DV
harvest at least 43 months prior to the study (n  151) were eligible for inclusion. Eighty-nine patients were excluded
(deceased  70; lost to follow-up  19). Forty-six patients who declined formal testing were queried by phone for signs
and symptoms of CVI. The current study presents a case-control series of 16 patients (27 limbs) after DV harvest and six
age- and gender-matched control patients (12 limbs) who underwent examination and venous testing.
Results:At amean follow-up of 70.1 5.6months, 23 of 27 limbs (85.2%) had no significant CVI (CEAPC0 to C2). Four
limbs (14.8%) had significant venous morbidity (C3 to C6), including edema alone (C3; n  2 limbs), edema with skin
changes (C4; n 1 limb), and a healed venous ulceration (C5; n 1 limb). APG testing confirmed relative venous outflow
obstruction after DV harvest (mean outflow fraction: harvested limbs  38.4  3.9% vs control limbs  51.7  4.3%;
P  .04). Despite the relative outflow obstruction, the mean VFI was not significantly different between harvested and
control limbs (harvested limbs  1.08  0.15% vs control limbs  0.77  0.16%; P  .19). DV harvest resulted in no
significant changes in calf ejection fraction (harvested limbs  67.4  6.4% vs control limbs  86.8  9.5%; P  .09) or
residual volume fraction measured (harvested limbs 32.3 6.4% vs control limbs 47.7 11.6%; P .22). Of the 46
patients interviewed by phone, five (10.9%) reported bilateral amputations, seven (15.2%) reported chronic edema in their
harvested limbs (C3), and 34 (73.9%) reported no signs of CVI in their harvested limbs (C0).
Conclusions: Deep vein harvest produces few symptoms of chronic venous insufficiency, and venous ulceration is
infrequent. Despite relative venous outflow obstruction, noninvasive indices of chronic venous insufficiency on APG are
often normal, suggesting that the risk of developing venous ulceration is low in the majority of patients after DV harvest.
(J Vasc Surg 2007;46:520-5.)Harvesting of the deep veins (DV) of the thigh, includ-
ing the femoral and popliteal veins, for use as conduits for
arterial reconstruction was initially described by Schulman
for femoral-popliteal arterial bypass.1-4 Our group subse-
quently described the use of DV for creation of a neo-
aortoiliac system (NAIS) for in situ aortic reconstruction
after excision of infected aortic prosthetic grafts.5-7 DV has
also been employed as an alternative conduit for brachio-
cephalic and mesenteric arterial reconstruction.8,9 Al-
though DV has proved to be relatively resistant to infection
and offers excellent long-term patency, interruption of the
venous drainage of the lower extremity by DV harvest
remains a concern to many surgeons.
DV harvest impedes venous outflow from the leg and
induces relative venous hypertension in the harvested
limb.10 In the immediate postoperative period, this venous
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520hypertension has been associated with compartment syn-
drome necessitating fasciotomy in 17.8% of limbs after DV
harvest.11 The incidence of chronic venous morbidity re-
mains undefined. We previously reported that approxi-
mately one-third of patients manifested mild leg swelling at
a mean follow-up of 37  3 months after DV harvest.10
Since there may be a lag time of several years between
venous injury and the clinical onset of chronic venous
insufficiency (CVI), quantifying venous morbidity after
short- or intermediate-term follow-up may not accurately
represent the long-term risk of developing CVI after DV
harvest. The purpose of this study was to define the late
incidence of chronic venous sufficiency and to characterize
the alterations in venous physiology that persist several
years after DV harvest.
MATERIAL AND METHODS
Study population. Since 1991, 269 patients have un-
dergone arterial reconstructions using DV at the University
of Texas Southwestern Medical Center and its affiliated
hospitals. Only patients with DV harvest at least 43 months
prior to the study (n  151) were eligible for inclusion.
After exclusion of patients who were deceased (n  70) or
lost to follow-up (n  19), 62 eligible patients were con-
tacted by phone. The current study represents a case-
control series of 16 patients (28 harvested limbs) and six
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out DV harvest who consented to participate. Patients who
declined to participate in the experimental protocol (n 
46) were queried by phone regarding signs and symptoms
of CVI. The study was conducted in accordance with a
protocol approved by the institutional review board of the
University of Texas Southwestern Medical Center.
Assessment for CVI. The standard protocol to assess
for CVI included clinical examination, lower extremity
venous duplex ultrasound, venous function testing, and
ankle-brachial indices (ABI). Clinical symptoms were cate-
gorized according to the CEAP system for classification of
lower-extremity venous disease.12,13 Measurements of leg
circumference were obtained at the thigh (14 cm above the
knee joint), proximal and mid-calf (3 cm and 10 cm below
the tibial tuberosity, respectively), and ankle.
Venous duplex ultrasound was performed with the
patient in recumbent position using a 5.0 MHz probe
(Acuson 128XP, Mountain View, Calif). Duplex exams
included the great saphenous vein (GSV), small saphenous
vein (SSV), and deep veins proximal and distal to the site of
DV harvest. Venous reflux was assessed using the rapid
cuff deflation duplex technique described by van Bem-
melen et al.14 Testing was performed with the patient
standing, but without weight-bearing on the limb. Reversal
of flow was detected by duplex ultrasonography in the
venous segment proximal to the cuff. Abnormal reflux was
defined as reversal of venous flow exceeding 0.5 seconds. In
this manner, reflux was assessed in the common femoral
vein (CFV), profunda femoris vein (PFV), and posterior
tibial veins (PTV). An assessment of reflux in the superficial
veins (GSV and SSV) was also performed.
Postoperative venous function was assessed by air pleth-
ysmography (APG; Model APG-1000C, ACI Medical, San
Marcos, Calif), as described by Christopoulos et al.15 Preop-
erative APG testingwas not performed. Parameters quantified
byAPG included outflow fraction, venous filling Index (VFI),
calf ejection fraction, and residual volume fraction.
Statistical analysis. All variables were analyzed by
limb, except as indicated. Continuous data were expressed
as mean SEM. Normally distributed data were compared
between treatment groups using a Student t test. Nonpara-
metric data were compared between groups using a Mann-
Whitney test or Wilcoxon signed-ranks test as appropriate.
Categorical data were analyzed using the Fisher exact test
and Cochran-Armitage trend test. For all statistical analy-
ses, the threshold for significance was .05. Statistical analy-
sis was performed using SAS, version 9.13 (SAS Institute,
Inc, Cary, NC).
RESULTS
The current study examined 16 patients with 28 har-
vested limbs (“study patients”) and six age- and gender-
matched control patients (12 limbs) without DV harvest
(“control patients”). The cohort of patients with DV har-
vest included 12 (75%) males and four (25%) females.
Control patients included four (66.7%) males and two
(33.3%) females. The mean age of study patients was58.3  3.2 years, while the mean age of control patients
was 64.2  2.4 years (P  .29). The mean follow-up was
for study patients was 70.1 5.6 months (range 43 to 129
months, median 66.0 months). Indications for DV harvest
included infected prosthetic aortic grafts (n  7), primary
aortoiliac reconstruction in young patients with premature
atherosclerosis (n  6), brachiocephalic reconstructions in
contaminated operative fields (n  2), and secondary aor-
toiliac reconstruction after a failed prosthetic aortofemoral
bypass (n  1). The mean preoperative ABI was 0.79 
0.07 for study patients and 0.84  0.7 for control patients
(P  .64). Five limbs (17.9%) had a history of prior GSV
harvest in a limb in which DV harvest was performed.
The technique for DV harvest has been described in
detail elsewhere.5,16 DV harvest was defined as complete if
the entire superficial femoral vein and any portion of the
popliteal vein below the adductor hiatus were harvested.
Complete DV harvest was performed in 26 of 28 (92.8%)
limbs. Among study patients, DV harvest was performed
bilaterally in 12 of 16 (75%) patients. Fasciotomy was
required at the time of DV harvest in eight of 28 (28.6%)
limbs. Concurrent GSV harvest was performed in two limbs
(7.2%) undergoing DV harvest, and both limbs required
fasciotomy. One limb required a below-knee amputation in
the perioperative period, while a second limb had an above-
knee amputation 43 months after bilateral DV harvest.
The incidence of venous disease is outlined in Table I.
For comparison, Table I includes harvested limbs, unhar-
vested limbs contralateral to a unilateral harvested limb,
and control patients with noDV harvest in either extremity.
After DV harvest, a minority of harvested limbs (four of 27;
14.8%) had clinical evidence of significant venous disease,
defined as CEAP class C3 to C6 venous disease. The re-
maining harvested limbs had minimal or no venous disease.
The most advanced venous disease after DV harvest in-
cluded two limbs with edema alone (C3), one limb with
edema and skin changes (dermatosclerosis and hemosiderin
deposition; C4), and one limb with a healed venous ulcer
(C5). The patient with a healed ulcer developed a small
(1 cm diameter), unilateral venous ulceration 52 months
after bilateral DV harvest for creation of a neo-aortoiliac
Table I. Clinical classification of venous disease after DV
harvest
CEAP
classification
Harvested limbs
(n  27)
Unharvested limbs*
(n  4)
Control limbs†
(n  12)
C0 16 (59.3%) 3 (75%) 4 (33.3%)
C1 5 (18.5%) 1 (25%) 8 (66.6%)
C2 2 (7.4%) 0 0
C3 2 (7.4%) 0 0
C4 1 (3.7%) 0 0
C5 1 (3.7%) 0 0
C6 0 0 0
*Unharvested limbs had a contralateral DV harvest.
†Control limbs were from patients with no DV harvest in either lower
extremity.system, and the ulcer healed with local wound care. The
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(range 65 to 129 months) for limbs with CEAP class C3 to
C6 venous disease, which was not significantly different
than the interval after DV harvest for limbs with CEAP class
C0 to C2 venous disease (66.7  5.5 months; P  .32).
Among harvested limbs, there was not a statistically signif-
icant trend in the proportion of limbs with a higher class of
venous disease (CEAP class C3 to C6), compared with
control limbs (P  .11, Fisher exact test). Moreover, there
was not an increasing trend across the ordinal values of
venous disease among harvested limbs compared with con-
trol limbs (P  .36, Cochran-Armitage trend test).
To further assess the incidence of clinically apparent
venous disease after DV harvest, phone interviews were
obtained from patients who were unable to return for
examination. Of the 46 patients interviewed by phone, 5
(10.9%) reported bilateral amputations, 7 (15.2%) reported
chronic edema in their harvested limbs (CEAP class C3),
and 34 (73.9%) reported no signs or symptoms of CVI in
their harvested limbs (CEAP class C0).
The potential for DV harvest to induce chronic limb
swelling was assessed by measuring limb circumference
using a standard technique. For this analysis, unharvested
limbs from patients with unilateral DV harvest were com-
pared with harvested limbs in the same patient. There were
no significant differences in the mean limb circumferences
between harvested and unharvested limbs at the thigh,
proximal calf, mid-calf, or ankle (Table II).
Duplex ultrasound was used to assess for subclinical
venous reflux using the rapid cuff deflation duplex tech-
nique described by van Bemmelen et al.14 Five limbs were
excluded from this analysis due to a prior amputation
(n 2), inability to stand for the exam (n 2), and patient
time constraints (n  1). By this technique, venous reflux
was noted in 11 of 23 (47.8%) tested limbs after DV harvest
(Table III). Among the limbs with reflux detected by this
technique, the deep system (CFV, PFV, or PTV) was most
commonly affected (n  6). The superficial system alone
(n 4) or in combination with deep venous reflux (n 1)
demonstrated reflux in several limbs. Reflux was observed
in one of four unharvested limbs in patients with a con-
tralateral DV harvest. The reflux test was not performed on
control patients.
To characterize the adaptation of the limb to DV
Table II. Limb circumference after DV harvest
Measurement site
Harvested
limbs
Unharvested
limbs
P
value
Thigh circumference (cm) 58.9  3.7 56.6  2.9 .25
Proximal calf circumference
(cm) 36.6  1.8 35.6  2.0 .25
Mid-calf circumference (cm) 38.1  2.2 36.5  2.0 .13
Ankle circumference (cm) 22.6  0.9 22.0  0.9 .13
Harvested (n  4) and unharvested (n  4) limbs were compared for
patients with unilateral DV harvest.harvest and to assess the potential for future developmentof venous disease, limbs were examined further using APG.
The results of APG testing for harvested and unharvested
limbs are outlined in Table IV. Three limbs were excluded
from this analysis due to prior amputation (n  2) or
inability to comply with the protocol for the exam (n 1).
Relative venous obstruction was confirmed by the presence
of a significantly lower outflow fraction in harvested legs,
compared with unharvested and control limbs (Table IV;
P  .04). The mean values for VFI, residual volume frac-
tion, and calf ejection fraction were not significantly differ-
ent between harvested and unharvested limbs (Table IV).
More careful scrutiny of APG results noted that two of 25
harvested limbs had an abnormal VFI (1.8 and 3.6 mL/
sec). In addition, a minority of harvested limbs had an
abnormal residual volume fraction (n 4) or abnormal calf
ejection fraction (n  6). There was no significant differ-
ence in the mean follow-up for limbs with abnormal APG
results, compared with limbs with normal results for each
APG parameter.
Patients with unilateral DV harvest (n  4) were as-
sessed for differences in venous function between the har-
vested and unharvested limbs within the same patient. No
significant differences in the mean VFI or calf ejection
fraction between harvested and unharvested limbs were
identified (data not shown).
The patient with a healed ulcer (CEAP class C5) was
carefully examined. On APG, the limb with a healed ulcer
had an outflow fraction that was on the lower margin of
normal (34.5%) normal VFI (1.2 mL/sec), and a modestly
decreased calf ejection fraction (46.9%). The contralateral
limb was normal in appearance, but yielded plethysmo-
graphic data that were comparable to the limb with prior
ulceration (data not shown).
Several patient and operative factors were examined for
possible association with the late development of chronic
venous disease, including concurrent DV and GSV harvest,
history of prior ipsilateral GSV harvest, diminished preop-
erative ABI, indication for surgery, and extent of DV har-
vest (complete vs subtotal). We found that concurrent GSV
harvest was associated with an increased incidence of sig-
nificant postoperative CVI (C3 to C6; P  .02) since both
limbs with concurrent GSV harvest developed persistent
postoperative edema (CEAP class C3). In contrast, a history
of prior GSV harvest in a limb undergoing DV harvest was
Table III. Venous reflux after DV harvest*
Site of venous reflux
Harvested limbs
(n  23)
Unharvested limbs†
(n  4)
No reflux 12 (52.2%) 3 (75%)
Deep venous reflux 6 (26.1%) 0
Superficial venous reflux 4 (17.4%) 1 (25%)
Deep and superficial reflux 1 (4.3%) 0
*Venous reflux assessed by rapid cuff deflation duplex technique described
by van Bemmelen.
†Unharvested limbs include only unharvested limbs from patients with a
unilateral DV harvest.not associated with late venous morbidity (P  .56), as
tients
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(CEAP class C0) and two limbs with prior GSV harvest had
telangectasias alone (CEAP class C1) after DV harvest.
There was no significant difference in ABIs among limbs
with minimal venous disease (C0 to C2) after DV harvest,
compared with those limbs with class C3 to C6 venous
disease (C0 to C2 0.80 0.07; C3 to C6 0.67 0.22;
P  .52). The indication for surgery also had no effect on
the incidence of CVI (P  .49). Subtotal DV harvest
produced no chronic venous disease, although there are
relatively few patients (n 2) who underwent subtotal DV
harvest in this series. Thus, concurrent GSV harvest was the
only factor that is clearly associated with significant late
venous morbidity.
DISCUSSION
DV harvest impedes venous outflow from the leg and
induces relative venous hypertension in the harvested
limb.10 The immediate implication of venous hypertension
is a risk of compartment syndrome requiring fasciotomy in
a minority (17.8%) of harvested limbs.11 The delayed
effects of DV harvest have not been well defined. At
intermediate-term follow-up (37  3 months), less than
one-third of patients experienced chronic mild edema
without skin changes (CEAP class C3). However, we
were concerned that there may be a lag time of several years
after DV harvest before the full extent of any venous
morbidity would be apparent clinically. The purpose of the
current study was to define the late incidence of CVI after
DV harvest by focusing exclusively on patients with DV
harvest at least 43 months prior to the study. An additional
goal of the study was to characterize the alterations in the
venous physiology of the leg after DV harvest to estimate
the perceived risk of future CVI.
Clinically significant venous disease, defined as CEAP
class C3 to C6, occurred in 14.8% of harvested limbs during
a mean follow-up of 70.1  5.6 months after DV harvest
(Table I). Only one limb developed venous ulceration,
which healed with local wound care (CEAP class C5).
Clinically apparent venous disease after DV harvest was
sufficiently infrequent that we were unable to demonstrable
a statistical association between DV harvest and the inci-
dence of late postoperative venous disease. Moreover,
mean limb circumference was no different between har-
vested and unharvested limbs when measured at the thigh,
proximal calf, mid-calf, or ankle (Table II).
The only clear risk factor for developing significant
Table IV. APG results after DV harvest
Parameter Harv
Outflow fraction [nl 38%] 38.4 
Venous filling index [nl  0.5-1.7 ml/sec] 1.08 
Residual volume fraction [nl  2-35%] 32.3 
Ejection fraction [nl  60-90%] 67.4 
*Unharvested limbs included control limbs and unharvested limbs from pavenous disease (CEAP class C3 to C6) after DV harvest wasconcurrent GSV harvest at the time of DV harvest. Two
limbs required concurrent GSV and DV harvest, and both
limbs developed postoperative edema without skin changes
(CEAP class C3). Despite the infrequency of concurrent
GSV harvest, this factor was strongly associated with signif-
icant postoperative venous disease (P .02). It is notewor-
thy that prior GSV harvest in an extremity undergoing DV
harvest was not associated with an increased likelihood of
developing significant venous disease postoperatively. No
additional factors, including the indication for surgery,
preoperative ABI, history of fasciotomy, and extent of DV
harvest, were associated with an increased risk of postoper-
ative venous disease.
Although clinically apparent, venous disease after DV
harvest was uncommon at late follow-up, we found that
nearly half (47.8%) of the harvested legs developed sono-
graphic evidence of venous reflux (Table III). Interestingly,
reflux was not always confined to the deep system, as the
superficial system showed evidence of reflux in five of 11
limbs with reflux. We hypothesize that reflux in the deep
and superficial systems alike is related to the relative venous
outflow obstruction created by DV harvest, which induces
pooling of blood and venous hypertension distal to the site
of harvest.10 A potential consequence of this increased
venous volume and hypertension may be poor apposition
of the venous valve leaflets, causing valvular incompetence
and venous reflux. This hypothesis is supported by our prior
observation that there appears to be compensatory enlarge-
ment of the GSV after DV harvest,10 allowing the GSV to
serve as a collateral outflow pathway in the harvested limb.
This pathophysiology contrasts with the combination of
both outflow obstruction and valvular injury that charac-
terizes deep venous thrombosis (DVT),17-19 which may
explain why DV harvest is tolerated with rare sequelae in
the majority of patients.
Further insight into the adaptation of the leg to DV
harvest was provided by our characterization of the venous
physiology by APG (Table IV). Venous outflow obstruc-
tion induced by DV harvest was reflected in a relatively
decreased outflow fraction (38.4  3.9%), compared with
unharvested limbs (51.7  4.3%; P  .04). However, the
ability of the limb to adapt to loss of the deep veins of the
thigh by recruiting venous collateral tracts, as described by
Raju20 and Masuda,21 was underscored by our observation
that the outflow fraction in harvested limbs was less than
published normal values (38%) in fewer than half of the
test limbs. Despite the relative outflow obstruction induced
limbs Unharvested limbs* P value
51.7  4.3% .04
ml/sec 0.77  0.16 ml/sec .19
47.7  11.6% .22
86.8  9.5% .09
with a contralateral DV harvest.ested
3.9%
0.15
6.4%
6.4%by DV harvest, the mean VFI was not different between
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harvested limbs had abnormal venous filling indices, sug-
gesting that reflux was uncommon after DV harvest. This
conclusion appears to contradict our finding of venous
reflux in nearly half of limbs assessed by the rapid cuff
deflation duplex technique (Table III). This apparent dis-
crepancy may be reconciled by recognizing that the two
parameters represent different approaches to the assess-
ment of reflux. The rapid cuff deflation technique quanti-
fies reflux in a specific vein upon rapid deflation of a cuff.
Only one vein may be assessed with each cuff deflation, so
the veins of the limb are tested individually in sequence. A
potential pitfall of the rapid cuff deflation technique is that
it fails to account for compensation by the veins not being
interrogated at the time of cuff deflation. By comparison,
the VFI provides a more global assessment of reflux in the
calf. The authors believe that the latter is more representa-
tive of the net effects of DV harvest on the limb. Moreover,
VFI has been correlated with an increased risk of develop-
ing venous ulceration.15,22 It should be noted that only one
limb had a VFI 2 ml/sec, which is a threshold associated
with a modest increase in risk of venous ulceration.22 With
a VFI of 3.6 ml/sec, this limb would not fall into the group
of limbs with the highest risk of venous ulceration (VFI5
ml/sec).22
Calf muscle pump function has been implicated by
some investigators as etiologic in the genesis of venous
ulceration.23,24 Although the mean ejection fraction for
harvested limbs was less than unharvested limbs, the differ-
ence was not significant (Table IV). It has also been sug-
gested that the combination of an increased VFI coupled
with a decreased calf ejection fraction is particularly predic-
tive of a risk of venous ulceration.23 In the current study, no
limb met both criteria. Taken together, these APG results
demonstrate the ability of the harvested limb to compen-
sate for the loss of venous outflow, which would explain the
lower rate of significant venous morbidity at late follow-up
(14.8%) compared with intermediate follow-up (32%).10
The APG data failed to reveal any alarming trends in the
APG parameters that have been most frequently associated
with a future risk of developing venous ulceration.15,22,23
There are several shortcomings to the present study
that are worthy of discussion. First, we assumed that any
edema in a harvested limb was caused by the DV harvest.
This assumption ignores other potential etiologies for limb
edema, including postrevascularization edema unrelated to
DV harvest, idiopathic CVI, and congestive heart failure.
As such, we may be over-estimating the true incidence of
significant CVI after DV harvest. In addition, the current
study represents a small sampling of our entire series.
Focusing exclusively on patients who underwent DV har-
vest at least 43 months prior to the study sharply reduced
the pool of potential subjects. Further attrition was related
to poor long-term survival and challenges in recruitment
associated with geographic distance and patient social cir-
cumstances. Low enrollment raises the possibility of a risk
of type II statistical error. The test most likely to be im-
pacted by this confounding issue was the mean ejectionfraction since the differences between harvested and unhar-
vested limbs approached significance (P  .09). Despite
this concern, any difference would not be viewed as clini-
cally significant since the mean ejection fraction of har-
vested limbs (67  6.4%) remained within normal limits
(60% to 90%). A further concern relates to the time course
for development of the most serious manifestations of CVI,
such as venous ulceration. The mean follow-up for the
study patients was 70.1 5.6 months. The authors cannot
exclude the possibility that a fraction of limbs that are
currently without significant venous disease may progress
and develop venous ulceration in the future. However, this
possibility is unlikely based on the time course of CVI after
deep venous thrombosis. In patients with deep venous
thrombosis, CVI usually develops within 1 to 2 years after
the initial venous insult, and it is rare to develop venous
complications more than 5 years later.25,26
In summary, DV harvest produces few symptoms of
CVI, and venous ulceration is infrequent at late follow-up.
Despite relative venous outflow obstruction, noninvasive
indices of chronic venous insufficiency on APG are usually
normal, suggesting that the risk of developing venous
ulceration is low in the vast majority of patients after DV
harvest. DV remains a viable option as an alternative con-
duit with few long-term sequelae for the limb.
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Dr Thomas S. Huber (Gainesville, Fla). Dr Modrall and his
colleagues from the University of Texas Southwestern have docu-
mented the incidence of late venous morbidity after harvest of the
superficial femoropopliteal vein and have thereby provided the
final piece of data that we have all awaited. Somewhat surprisingly,
they found that the deep vein harvest resulted in clinically signifi-
cant venous morbidity only 15% of the time, while the sophisti-
cated venous testing with air plethysmography was not particularly
worrisome for the development of future events. Notably, concur-
rent harvest of the saphenous and deep veins was the only factor
clearly associated with the development of late morbidity.
The study contributes to our overall understanding of the
venous pathophysiology after deep vein harvest and documents the
presence of significant venous obstruction, but no clinically signif-
icant changes in reflux, or calf muscle pump or residual venous
volume, a surrogate for ambulatory venous pressure. Their find-
ings both extend and corroborate their intermediate-term results
and offer reassurance to those of us that find it necessary to harvest
the superficial femoropopliteal more commonly than we care to
admit. I have three requests and/or questions for the authors:
Despite the authors’ overwhelming experience with the use of
the superficial femoropopliteal vein, I was somewhat concerned by
their small sample size and retrospective study design. Please
comment on any potential selection bias and the potential for a
type II statistical error.
Please describe your preoperative evaluation and management
strategies for a typical patient with an infected aortobifemoral
bypass graft and severe peripheral vascular occlusive disease that
requires a NAIS and possibly a concomitant infrainguinal bypass.
Please describe how we should counsel our patients in the
perioperative period and detail any further adjuncts or techniques
used to achieve these excellent results.
Overall, I strongly recommend the manuscript to the organi-
zation and the readership of the Journal. It is the type of study that
we expect from the Southwestern group and one that contributes
significantly to our clinical practices.
Dr J. Gregory Modrall: In regard to your first question,
there is no question that this is a small sampling of our overall
experience. When you look at the numbers we started with, we firstafter their deep vein harvest, which dropped the number tremen-
dously.
Furthermore, the nature of our practice is such that we have a
university hospital and two hospitals with large numbers of indi-
gent patients. The indigent patients are often difficult to track
down and reluctant to come back for unnecessary studies. Patients
at our university hospital referral practice come from across the
country, and it is difficult to compel them to come back for
follow-up that is for research purposes alone.
The risk of a type II error probably is only pertinent to the
results obtained for calf ejection fraction because the is P value for
this comparison between harvested and control limbs approached
significance. I will point out that approximately two-thirds of those
patients had ejection fractions that were above the median and
within normal limits, which is somewhat reassuring.
Regarding our preoperative evaluation andmanagement strat-
egies, we always obtain sonographic deep vein mapping before
deep vein harvest. This study is used to identify any pathology of
the deep vein, including any sclerotic or occluded veins, to obtain
a baseline measurement of the vein, and to identify any variant
anatomy, such as a bifurcated superficial femoral vein. We also look
at the status of the ipsilateral saphenous vein in the event that an
outflow procedure is necessary.
A common question that is raised is whether a concurrent
outflow procedure is safe, knowing that this predisposes to acute
and chronic venous morbidity. Our philosophy is to save the limb
and worry about the minority of patients who develop these
problems at a later time. We do, however, always counsel patients
about the potential for acute venous morbidity, that being a
fasciotomy, and a late chronic venous insufficiency.
In answer to your last question, the only adjunctive technique
is the careful preservation of the profunda femoris vein and harvest
the superficial femoral vein flush from its confluence with the
profunda vein to avoid leaving a stump that may become a nidus
for clot formation. In addition, we take only the length of vein that
is required, because sparing the popliteal vein virtually assures the
patient of avoiding both acute and long-term venous morbidity.
We have never had a harvested limb develop acute or chronic
venous morbidity if the popliteal vein was not harvested.
